tirzepatide effects on brain Beyond glycemia: Comparing to GLP-1 analogues Tirzepatide reveals a brain signal

Similarly, it improved cerebral energy metabolism in ischemic rat brain (Suzuki et al., 2001) and prevented glutamate mediated neuronal toxicity and lipid peroxidation (Meja-Toiber et al., 2006)

By activating GLP-1 receptors, semaglutide helps: Stimulate insulin production when blood sugar is high Reduce glucagon secretion, which further lowers blood sugar Slow down digestion, promoting a feeling of fullness Decrease appetite by acting on brain centers controlling hunger The FDA has approved Ozempic for the treatment of type 2 diabetes, while Wegovy, a higher-dose formulation of semaglutide, is specifically approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity

Details here

When combined with professional monitoring, it creates confidence

[DOI] [PMC free article] [PubMed] [Google Scholar] 92.Sabogal-Guqueta A.M., Muoz-Manco J.I., Ramrez-Pineda J.R., Lamprea-Rodriguez M., Osorio E., Cardona-Gmez G.P